SCHEMBL19968034

SCHEMBL19968034

Cc1nc(Nc2ncc(F)c(-c3cc(F)c4nc(C)n(C(C)C)c4c3)n2)ccc1C(=O)N1CCCN(CC(F)(F)F)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.64
CDK2 P24941 17/20 0.64
CDK6 Q00534 17/20 0.64
CDK1 P06493 9/20 0.57
CCNB1 P14635 7/20 0.57
CCNE1 P24864 7/20 0.57
CDK9 P50750 6/20 0.57
CDK7 P50613 5/20 0.57
CCNA2 P20248 2/20 0.56
CCND3 P30281 2/20 0.56
CIT O14578 1/20 0.56
GAK O14976 1/20 0.56
DYRK3 O43781 1/20 0.56
CCNT1 O60563 1/20 0.56
STK16 O75716 1/20 0.56
CCNK O75909 1/20 0.56
STK10 O94804 1/20 0.56
PRKD3 O94806 1/20 0.56
ABCB11 O95342 1/20 0.56
MAP4K4 O95819 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19968040 0.93 CDK4 (0.66) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968116 0.91 CDK4 (0.64) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968055 0.90 CDK4 (0.61) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968129 0.90 CDK4 (0.64) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968032 0.89 CDK4 (0.63) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968062 0.89 CDK4 (0.57) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19967971 0.87 CDK4 (0.62) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL17489032 0.87 CDK6 (0.66) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19967972 0.86 CDK4 (0.60) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL19968023 0.85 CDK4 (0.59) CDK4CDK2CDK6CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018045956-A1 BENZIMIDAZOLE COMPOUND KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2018-03-15 WO disclosed